Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;78(2):180-4.
doi: 10.1007/BF00432259.

Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat

Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat

D M Coward. Psychopharmacology (Berl). 1982.

Abstract

The present study compared the ability of neuroleptic and non-neuroleptic agents to modify the sensitivity of nigral, GABA-sensitive, non-dopaminergic efferents in the rat after sub-chronic administration. Pre-treatment with haloperidol or clebopride, 1.0 mg/kg PO for 10 days, induced supersensitivity to the behavioural effects of unilateral intranigral muscimol, 5.0 ng, on withdrawal day 1. This effect was no longer significant in other rats tested on withdrawal day 7. In contrast, similar pre-treatment with sulpiride, 20 mg/kg PO, led to significantly enhanced responses to intra-nigral muscimol on both withdrawal days. Pre-treatment with clozapine, 20 mg/kg, or thioridazine, 12 mg/kg PO, did not lead to supersensitivity on withdrawal day 1, but did so on withdrawal day 7. Pre-treatment with amitriptyline, 20 mg/kg PO, or metoclopramide, 1.0 mg/kg PO, failed to result in supersensitivity on either withdrawal day. The data confirm previous biochemical and behavioural findings suggesting that repeated administration of neuroleptics can induce nigral GABA-ergic supersensitivity in the rat, but demonstrate that this action is not an exclusive property of classical, cataleptogenic agents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 1981 Jul 20;216(2):437-43 - PubMed
    1. Psychopharmacologia. 1974;39(2):105-19 - PubMed
    1. Neurosci Lett. 1977 Jun;5(1-2):75-82 - PubMed
    1. Eur J Pharmacol. 1978 Jun 1;49(3):233-41 - PubMed
    1. Nature. 1980 Feb 7;283(5747):569-70 - PubMed

Substances

LinkOut - more resources